The high demand for Biotres Pro, leading to a sold-out initial production and pre-orders for the next, indicates strong market acceptance and potential revenue growth. The expected increase in subscription prices by over 32% and revenue by up to 10% from sales to existing customers through 2025 suggests a positive outlook for Biotricity's financial performance. This news is directly related to Biotricity and is critical for investors, as it impacts revenue projections and market share expansion.